Having recently embarked on my own commentary of the Pharmaceutical industry, I was intrigued to read a recent article listing 6 ways Pharma may use social media. 

The article itself provides some great points around topics such as education, clinical trial recruitment, listening etc, but my questions are raised from an end of article warning to carefully review guidance from the FDA. 

With so much digital content created on a daily basis by thousands of companies, I'm interested to learn how thorough regulator checks and surveillance can manage/audit this daily expanding market?